Fudosteine
Alternative Names: Cleanal; Spelear; SR 320; SS 320; SS 320ALatest Information Update: 09 Jan 2008
At a glance
- Originator Hisamitsu Pharmaceutical
- Developer Mitsubishi Tanabe Pharma Corporation
- Class Antitussives; Diamino amino acids; Dicarboxylic amino acids; Disulfides; Expectorants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Bronchitis; Cough
Most Recent Events
- 01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation
- 01 Apr 2005 SSP Co. has sold its ethical drugs business to Hisamitsu Pharmaceutical
- 21 Jul 2004 Solution formulations of fudosteine have been launched in Japan